SARINA AKERS: Open Payments
NPI 1043781784 · CHAMBERSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 21 payments from 13 companies in 2025. Trend: 2023 $121 · 2024 $542 · 2025 $528
Food & beverage: $423Education: $104
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $165 |
| Axsome Therapeutics, Inc. | 1 | $78 |
| ABBVIE INC. | 3 | $75 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: Auvelity, VRAYLAR, UZEDY, SPRAVATO, CAPLYTA, Qelbree, Jornay PM, LOREEV XR.
Industry payments across PA — which companies pay providers there.
